Tandem Diabetes Care Inc (TNDM)
28.51
-0.08
(-0.28%)
USD |
NASDAQ |
Nov 15, 09:40
Tandem Diabetes Care Free Cash Flow (Quarterly): 21.54M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 21.54M |
June 30, 2024 | -11.74M |
March 31, 2024 | -12.45M |
December 31, 2023 | -34.70M |
September 30, 2023 | -5.345M |
June 30, 2023 | -14.22M |
March 31, 2023 | -29.15M |
December 31, 2022 | 0.193M |
September 30, 2022 | 1.893M |
June 30, 2022 | -5.731M |
March 31, 2022 | 11.16M |
December 31, 2021 | 13.89M |
September 30, 2021 | 31.05M |
June 30, 2021 | 17.75M |
March 31, 2021 | 25.16M |
December 31, 2020 | 11.14M |
September 30, 2020 | 7.723M |
June 30, 2020 | 0.908M |
March 31, 2020 | -27.40M |
December 31, 2019 | 12.69M |
September 30, 2019 | 18.40M |
June 30, 2019 | -3.193M |
March 31, 2019 | -5.532M |
December 31, 2018 | 13.24M |
Date | Value |
---|---|
September 30, 2018 | -4.468M |
June 30, 2018 | -7.296M |
March 31, 2018 | -12.79M |
December 31, 2017 | -13.06M |
September 30, 2017 | -19.26M |
June 30, 2017 | -16.08M |
March 31, 2017 | -23.46M |
December 31, 2016 | -16.32M |
September 30, 2016 | -20.29M |
June 30, 2016 | -15.60M |
March 31, 2016 | -17.89M |
December 31, 2015 | -11.92M |
September 30, 2015 | -16.08M |
June 30, 2015 | -20.51M |
March 31, 2015 | -16.10M |
December 31, 2014 | -14.28M |
September 30, 2014 | -14.55M |
June 30, 2014 | -18.37M |
March 31, 2014 | -18.75M |
December 31, 2013 | -14.31M |
September 30, 2013 | -13.57M |
June 30, 2013 | -15.68M |
March 31, 2013 | -10.21M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-34.70M
Minimum
Dec 2023
31.05M
Maximum
Sep 2021
0.7181M
Average
1.400M
Median
Free Cash Flow (Quarterly) Benchmarks
Boston Scientific Corp | 698.00M |
Masimo Corp | 9.40M |
RxSight Inc | -0.453M |
Perspective Therapeutics Inc | -9.917M |
Xtant Medical Holdings Inc | -5.652M |